Literature DB >> 33750209

Exploring New and Old Therapies for Obstructive Hypertrophic Cardiomyopathy: Mavacamten in Perspective.

Martin S Maron1, Steve R Ommen2.   

Abstract

Entities:  

Keywords:  drug therapy; heart failure; hypertrophic cardiomyopathy; myectomy

Mesh：

Substances：

Year:  2021        PMID： 33750209     DOI： 10.1161/CIRCULATIONAHA.120.051330

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  2 in total

1.  Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Authors:  Barry J Maron; Martin S Maron; Mark V Sherrid; Ethan J Rowin
Journal:  J Am Heart Assoc       Date:  2022-05-03       Impact factor: 6.106

2.  Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.

Authors:  Mengyao Zhou; Shengjun Ta; Rebecca T Hahn; David H Hsi; Martin B Leon; Rui Hu; Jun Zhang; Lei Zuo; Jing Li; Jing Wang; Bo Wang; Xiaoli Zhu; Jiani Liu; Yupeng Han; Xiaojuan Li; Bo Xu; Lei Zhang; Lihong Hou; Chao Han; Jincheng Liu; Liwen Liu
Journal:  JAMA Cardiol       Date:  2022-05-01       Impact factor: 30.154
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.